Elevance Health Inc. ELV NYSE

Elevance Health Inc. (ELV) reported total assets of $121.49B and total liabilities of $77.47B for fiscal year 2025, resulting in total equity of $44.03B.

The company held $9.49B in cash and short-term investments. Total debt stood at $33.24B, with net debt of $23.74B. The Debt-to-Equity (D/E) ratio was 0.75 (moderate).

Current ratio is 1.24, suggesting adequate short-term liquidity. Interest coverage is 5.8x (adequate).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (63/100) — Total assets $121.49B and equity $44.03B support the company's competitive scale
• VALUE (69/100) — Debt-to-Equity 0.75 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.

UNH

UnitedHealth Group Incorporated

$314.19

+0.38%

GSK

GSK plc

$59.18

+0.41%

CVS

CVS Health Corporation

$77.62

-0.60%

REGN

Regeneron Pharmaceuticals, Inc.

$755.51

+1.21%

CI

Cigna Corporation

$272.60

-0.92%

COR

Cencora, Inc.

$319.90

+0.24%

BDX

Becton, Dickinson and Company

$155.73

+0.19%

ZTS

Zoetis Inc.

$121.11

+0.86%